Medial EarlySign ^{For Profit}

Medial EarlySign is an organization that focuses on early detection and prevention of high-burden diseases using routine, existing electronic health record (EHR) data. They have developed an AI algorithmic platform called AlgoMarkers, which analyzes basic medical information like blood test results and EMR data to predict the likelihood of disease. Their platform is built in collaboration with healthcare organizations and combines millions of patient years-worth of data with clinical rigor and advanced algorithms. Medial EarlySign's solutions assist in the early prediction of clinical outcomes related to cancers, metabolic, immune, and infectious diseases, empowering healthcare organizations with proactive and personalized care management capabilities. They are currently working with global healthcare partners to improve early detection of colorectal and lung cancer in populations over the age of 40.